Background: This study evaluated the inflammatory reaction at the site of overlapping drug-eluting stents (DES) in a porcine model of in-stent restenosis, Methods and Results: Twenty bare metal stents (BMS) (group I; n=10), 20 sirolimus-eluting stents (SES) (group II: n=10), 20 paclitaxel-eluting stent (PES) (group III n=10), and 10 PES and 10 SES (group IV: n=10) were overlapped in the left anterior descending coronary arteries of 40 pigs. Follow-up coronary angiography and histopathology were performed at 4 weeks after stenting. For the overlapped segments, the minimal luminal diameter at 4 weeks was smaller in group I than in the other groups (1.78±0.13mm, 2.79±0.09mm, 2.90±0.04mm, 2.80±0.07mm, respectively; p<0.001), and the neointimal area (5.51±0.58mm2, 2.38±0.53mm2, 2.07±0.37mm2, 2.39±0.58mm2, respectively; p<0.001) and area stenosis (68.74±4.02%, 27.79±4.73%, 23.66±3.24%, 27.63±4.07%, respectively; p<0.001) were higher in group I than in the outer groups; however, the inflammatory score was higher in group III than in the other groups (1.80±0.42, 2.10±0.32, 2.90±0.31, 2.50±0.52, respectively; p<0.001) and the endothelization score was lower in group III than in the other groups (2.80±0.42, 2.30±0.67, 1.30±0.48, 2.10±0.74, respectively; p<0.001). Conclusion: Compared with BMS, DES inhibit neointimal hyperplasia, but inflammation and poor endothelization occur at the site of overlapping stents.
- Coronary disease
- Drug-eluting stent
- Stent thrombosis
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine